Chen et al. found that PDE10A inhibition not only reduced ovarian cancer cells growth and induced cell apoptosis, but also enhanced the chemotherapy efficacy of doxorubicin (DOX) on ovarian cancer, preventing DOX induced cardiac toxicity and dysfunction. This evidence concerns the gene PDE10A and ovarian cancer.